SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,670.00    20.00 (0.35%)
Bid:
5,660.00
Ask:
5,670.00
Spread: 10.00 (0.177%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Third Quarter Trading Statement

1 Feb 2018 07:00

RNS Number : 5448D
Cranswick PLC
01 February 2018
 

 

 

1 February 2018

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

Third quarter trading statement

 

Cranswick, a leading UK food producer, today provides an update on trading for the three months to 31 December 2017.

 

Current trading

Total and like-for-like revenue* were both ahead of the prior year. Each of the Group's categories delivered positive volume growth, with this growth underpinned, as anticipated, by a strong performance over the key Christmas trading period. Total export sales were also well ahead.

 

The UK pig price continued to ease during the period, ending the quarter at a similar level to that of a year earlier. This downward trend is being reflected in selling prices.

 

Trading during the third quarter of the financial year was slightly ahead of the Board's expectations.

 

Investment

The Group continues to invest at record levels across its asset base to increase capacity, add new capability and drive further operating efficiencies.

 

Construction of the new Continental Products facility, based at Bury in Lancashire, is well advanced and progressing to plan, with completion expected in the first half of the next financial year. When finished, the site will consolidate production from the Group's two existing Continental Products facilities, lift capacity by approximately 70 per cent, add new capability and drive efficiency improvements on existing product ranges.

 

Plans for the new primary poultry facility in Eye, Suffolk continue to be developed, with construction, subject to receiving planning approval in the coming weeks, expected to begin in quarter one of the next financial year. This class-leading facility, which is scheduled for completion in late 2019, will double existing capacity with further room for expansion. The facility will incorporate the highest animal welfare standards and latest generation production techniques and equipment to drive operational efficiency gains.

 

Financial position

During the period, the Group extended its banking facility for a further 12 months on existing terms. The agreement, which now extends to November 2022 with the potential to extend for a further year, comprises a revolving credit facility of £160 million, including a committed overdraft of £20 million. This unsecured facility supports the Group's sound financial position and provides significant headroom for future growth.

 

Net debt increased during the quarter, albeit it was below the level at the same stage last year, reflecting the anticipated seasonal increase in working capital and ongoing capital expenditure.

 

Outlook

With experienced management at all levels of the Group, a strong range of products, a well-invested asset base and a robust financial position, the Board is confident in both the prospects for the remainder of the current financial year and the continued long-term success and development of the business.

 

Preliminary results

The Company's next scheduled comment on trading will be the preliminary results announcement on 22 May 2018.

 

Enquiries:

 

Cranswick plc

01482 372 000

Mark Bottomley, Finance Director

Powerscourt

020 7250 1446

Nick Dibden / Lisa Kavanagh

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, premium fresh and cooked poultry, charcuterie and pastry products. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2017 showed revenue from continuing operations of £1,245m and profit before tax on the same basis of £77.5m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

* Like-for-like revenue excludes the contribution from acquired businesses in the current year prior to the first anniversary following the date of acquisition.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDLRILVIT
Date   Source Headline
1st Feb 202210:25 amRNSTotal Voting Rights
31st Jan 20227:00 amRNSAcquisition of dry pet food producer
27th Jan 20229:03 amRNSListing of Ordinary Shares
19th Jan 20223:31 pmRNSHolding(s) in Company
4th Jan 202211:32 amRNSTotal Voting Rights
24th Dec 202110:55 amRNSCranswick Scrip Dividend Scheme
3rd Dec 20219:49 amRNSTotal Voting Rights
29th Nov 20213:24 pmRNSHolding(s) in Company
25th Nov 20214:50 pmRNSDirector/PDMR Shareholding
23rd Nov 20215:35 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSInterim Results
4th Nov 20218:43 amRNSHolding(s) in Company
1st Oct 202112:45 pmRNSBlock listing Interim Review
1st Oct 202112:44 pmRNSBlock listing Interim Review
1st Oct 202112:40 pmRNSTotal Voting Rights
30th Sep 20215:16 pmRNSHolding(s) in Company
27th Sep 20213:55 pmRNSDirector/PDMR Shareholding
27th Sep 20213:54 pmRNSDirector/PDMR Shareholding
3rd Sep 202112:18 pmRNSUpdate re Listing of Ordinary Shares
2nd Sep 20218:42 amRNSListing pursuant to Scrip Shares and TVR
1st Sep 20214:34 pmRNSTotal Voting Rights
12th Aug 20215:55 pmRNSHolding(s) in Company
11th Aug 20212:25 pmRNSDirector/PDMR Shareholding
11th Aug 20212:24 pmRNSDirector/PDMR Shareholding
11th Aug 20212:24 pmRNSDirector/PDMR Shareholding
11th Aug 20212:20 pmRNSDirector/PDMR Shareholding
11th Aug 20212:20 pmRNSDirector/PDMR Shareholding
3rd Aug 202111:53 amRNSDirector/PDMR Shareholding
3rd Aug 202111:50 amRNSTotal Voting Rights
29th Jul 20212:48 pmRNSCRANSWICK SCRIP DIVIDEND SCHEME
26th Jul 20212:58 pmRNSDirector/PDMR Shareholding
26th Jul 20212:57 pmRNSDirector/PDMR Shareholding
26th Jul 20212:50 pmRNSAppointment of Chairman and Poll Result -2021 AGM
26th Jul 20212:48 pmRNSTransaction in Own Shares
26th Jul 20217:00 amRNSFirst quarter trading statement
13th Jul 20211:45 pmRNSANNUAL GENERAL MEETING 2021 – UPDATE
12th Jul 20213:46 pmRNSHolding(s) in Company
1st Jul 20218:59 amRNSTotal Voting Rights
24th Jun 20219:00 amRNSHolding(s) in Company
18th Jun 20212:24 pmRNSHolding(s) in Company
1st Jun 20212:35 pmRNSDirector/PDMR Shareholding
1st Jun 20212:25 pmRNSTotal Voting Rights
1st Jun 20212:24 pmRNSDirector/PDMR Shareholding
21st May 202111:00 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
20th May 202112:08 pmRNSDirector/PDMR Shareholding
20th May 202112:06 pmRNSDirector/PDMR Shareholding
20th May 202112:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.